Orca Capital AG

13F Holdings History for Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Symbol: CANF on NYSE
Investment type: Equity / Ordinary Shares, no par value
Latest Disclosed Ownership: 157M shares
Security Ownership: 4.1%

Orca Capital AG ownership in Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF)

2025-04-23 - Orca Capital AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 157M shares of Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF). This represents 4.1% percent ownership of the company. In their previous filing dated 2025-04-16, Orca Capital AG had reported owning 375M shares, indicating a decrease of -58% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Orca Capital AG	4.1%	-56%	$220M	157M	-217,617,300	-58%	$1.40	13G/A	4/22/2025	23 Apr 2025 16:30:25
Orca Capital AG	9.7%		$525M	375M			$1.40	13G	4/14/2025	16 Apr 2025 16:30:03